Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 108 Records) |
Query Trace: Lung Neoplasms and STK11[original query] |
---|
Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China. OncoTargets and therapy 2022 9 15 1021-1032. Gu Guomin, Yu Bo, Wan Hua, Lu Suqiong, Zhu Xiaodan, Zhao Yan, Fuxi Yujing, Liu Chunli |
Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2022 Jun 172 85-95. Rosellini Pietro, Amintas Samuel, Caumont Charline, Veillon Rémi, Galland-Girodet Sigolène, Cuguillière Alain, Nguyen Laurent, Domblides Charlotte, Gouverneur Amandine, Merlio Jean-Philippe, Bezin Julien, Girodet Pierre-Olivi |
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP). Lung cancer (Amsterdam, Netherlands) 2022 Jun 170 114-121. Cordeiro de Lima Vladmir C, Corassa Marcelo, Saldanha Erick, Freitas Helano, Arrieta Oscar, Raez Luis, Samtani Suraj, Ramos Maritza, Rojas Carlos, Burotto Mauricio, Chamorro Diego F, Recondo Gonzalo, Ruiz-Patiño Alejandro, Más Luis, Zatarain-Barrón Lucia, Mejía Sergio, Nicolas Minata José, Martín Claudio, Bautista Blaquier Juan, Motta Guerrero Rodrigo, Aliaga-Macha Carlos, Carracedo Carlos, Ordóñez-Reyes Camila, Garcia-Robledo Juan Esteban, Corrales Luis, Sotelo Carolina, Ricaurte Luisa, Santoyo Nicolas, Cuello Mauricio, Jaller Elvira, Rodríguez July, Archila Pilar, Bermudez Maritza, Gamez Tatiana, Russo Alessandro, Viola Lucia, Malapelle Umberto, de Miguel Perez Diego, Rolfo Christian, Rosell Rafael, Cardona Andrés |
Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. Cell metabolism 2022 5 34 (6): 874-887.e6. Best Sarah A, Gubser Patrick M, Sethumadhavan Shalini, Kersbergen Ariena, Negrón Abril Yashira L, Goldford Joshua, Sellers Katherine, Abeysekera Waruni, Garnham Alexandra L, McDonald Jackson A, Weeden Clare E, Anderson Dovile, Pirman David, Roddy Thomas P, Creek Darren J, Kallies Axel, Kingsbury Gillian, Sutherland Kate |
Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic. Current oncology (Toronto, Ont.) 2022 5 29 (5): 3171-3186. Goss Glenwood D, Spaans Johanna N, Huntsman David, Asmis Timothy, Andrews Wright Natalie M, Duciaume Marc, Kaurah Pardeep, Miller Ruth R, Banerji Shantanu, Sekhon Harmanjatinder S, Gomes Marcio |
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes. Journal of personalized medicine 2022 3 12 (3): . Pop-Bica Cecilia, Ciocan Cristina Alexandra, Braicu Cornelia, Harangu? Antonia, Simon Marioara, Nutu Andreea, Pop Laura Ancuta, Slaby Ondrej, Atanasov Atanas G, Pirlog Radu, Al Hajjar Nadim, Berindan-Neagoe Ioa |
Landscape of KRAS, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers. JCO precision oncology 2022 3 6 e2100245. Salem Mohamed E, El-Refai Sherif M, Sha Wei, Puccini Alberto, Grothey Axel, George Thomas J, Hwang Jimmy J, O'Neil Bert, Barrett Alexander S, Kadakia Kunal C, Musselwhite Laura W, Raghavan Derek, Van Cutsem Eric, Tabernero Josep, Tie Jean |
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial. Journal for immunotherapy of cancer 2022 02 10 (2): . West Howard Jack, McCleland Mark, Cappuzzo Federico, Reck Martin, Mok Tony Sk, Jotte Robert M, Nishio Makoto, Kim Eugene, Morris Stefanie, Zou Wei, Shames David, Das Thakur Meghna, Shankar Geetha, Socinski Mark |
Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
Probing Mutant KRAS, STK11, KEAP1 in NSCLC. Cancer discovery 2022 Aug OF1. Authors are not available |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients. Cancers 2022 May 14 (10): . Ulivi Paola, Urbini Milena, Petracci Elisabetta, Canale Matteo, Dubini Alessandra, Bartolini Daniela, Calistri Daniele, Cravero Paola, Fonzi Eugenio, Martinelli Giovanni, Priano Ilaria, Andrikou Kalliopi, Bronte Giuseppe, Crinò Lucio, Delmonte Ange |
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer. Internal medicine (Tokyo, Japan) 2023 3 . Sumii Masahiko, Namba Masashi, Tokumo Kentaro, Yamauchi Masami, Okamoto Wataru, Hattori Noboru, Sugiyama Kazuhi |
[Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 117-123. Guo L Y, Xiang C, Zhao R Y, Chen S N, Ma S J, Han Y |
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations. Cancers 2023 11 15 (22): . Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Ju |
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort. Tumori 2023 10 3008916231204441. Andrea Olsen, Alexandra Lebedeva, Polina Nosova, Vladislav Nikulin, Margarita Sharova, Ekaterina Ignatova, Vladislav Mileyko, Maxim Ivan |
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO precision oncology 2023 1 7 e2200273. Katipally Rohan R, Spurr Liam F, Gutiontov Stanley I, Turchan William Tyler, Connell Philip, Juloori Aditya, Malik Renuka, Binkley Michael S, Jiang Alice L, Rouhani Sherin J, Chervin Carolina Soto, Wanjari Pankhuri, Segal Jeremy P, Ng Victor, Loo Billy W, Gomez Daniel R, Bestvina Christine M, Vokes Everett E, Ferguson Mark K, Donington Jessica S, Diehn Maximilian, Pitroda Sean |
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO precision oncology 2023 1 7 e2200540. De Brian, Farooqi Ahsan S, Mitchell Kyle G, Ludmir Ethan B, Lewis Jeff, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Lee J Jack, Swisher Stephen G, Gibbons Don L, Zhang Jianjun, Le Xiuning, Elamin Yasir Y, Gomez Daniel R, Ning Matthew S, Lin Steven H, Liao Zhongxing, Chang Joe Y, Vaporciyan Ara A, Heymach John V, Antonoff Mara B, Gandhi Saumil |
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Mok T S K, Lopes G, Cho B C, Kowalski D M, Kasahara K, Wu Y-L, de Castro G, Turna H Z, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza M C, Piperdi B, Herbst R |
Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses. BMC cancer 2024 4 24 (1): 491. Ke Xu, Weinan Lu, Airu Yu, Hongwei Wu, Jie |
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: